Vical Completes Final Patient Follow-Up in transvax CMV Vaccine Phase 2 Trial
Tuesday, 24 November 2009
Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced it has acquired privately ...